James Taylor BASc, PhD

James is the CEO and co-founder of Precision NanoSystems, Inc. (PNI), a commercial stage biotechnology company at the convergence of nanotechnology, genomics, and personalized medicine. PNI empowers researchers to advance the application of nanoparticles to the understanding and treatment of disease. PNI’s versatile NanoAssemblr nanoparticle formulation platform enables rapid, reproducible, and scalable lipid and polymer nanoparticle formulations. James has a B.A.Sc. in engineering physics from UBC and a Ph.D. in genetics from the Institute for Systems Biology in Seattle, WA. James worked at the Seattle based Venture Capital firm, the Accelerator Corporation concurrent with his Ph.D. and has extensive experience in the science and commercialization of microfluidics, nanotechnology, and systems biology. James has been the leader of PNI since its inception.